Stuart Ellison

735 citations

27 papers · 552 indexed · h-index 14

Impact in

Hematology top 10%
- Platelet Disorders and Treatments
Immunology and Allergy top 10%
- Cell Adhesion Molecules Research

Papers in ⓘ

Genetics 5
- Virus-based gene therapy research 6
- Neurogenetic and Muscular Disorders Research 4
Physiology 11
- Lysosomal Storage Disorders Research 11

Co-authors: Brian Bigger (17 shared papers)Helen Parker (7 shared papers)Yotis A. Senis (3 shared papers)Antonio Trabalza (5 shared papers)Steve P. Watson (2 shared papers)Aiyin Liao (5 shared papers)Jun Mori (2 shared papers)Rebecca Holley (9 shared papers)
Journals: Molecular Genetics and Metabolism (6 papers)Molecular Therapy — Methods & Clinical Development (3 papers)Blood (3 papers)Human Gene Therapy (2 papers)Molecular Therapy (2 papers)
Partner nations: United Kingdom United States Germany

In The Last Decade

Stuart Ellison

26 papers receiving 551 citations

Peers

Countries citing papers authored by Stuart Ellison

Since Specialization

Citations

This map shows the geographic impact of Stuart Ellison's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Stuart Ellison with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Stuart Ellison more than expected).

Fields of papers citing papers by Stuart Ellison

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Stuart Ellison. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Stuart Ellison. The network helps show where Stuart Ellison may publish in the future.

Co-authors

The 25 scholars most cited alongside Stuart Ellison, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Stuart Ellison Line = papers co-authored together Stuart Ellison links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Showing the 20 most-cited of 27 papers — load more, or switch the sort, to bring in the rest.

#	Work
1	The tyrosine phosphatase CD148 is an essential positive regulator of platelet activation and thrombosis Blood ·Yotis A. Senis, Michael G. Tomlinson, Stuart Ellison, Alexandra Mazharian, Jenson Lim, Yan Zhao, Kristin N. Kornerup, Jocelyn M. Auger, Steven G. Thomas, Tarvinder Dhanjal, Neena Kalia, Jing Zhu, Arthur Weiss, Steve P. Watson	2009	104
2	Macrophage enzyme and reduced inflammation drive brain correction of mucopolysaccharidosis IIIB by stem cell gene therapy Brain ·Rebecca Holley, Stuart Ellison, Daniel Fil, Claire O’Leary, John McDermott, Nishanthi Senthivel, Alex Langford-Smith, Fiona L. Wilkinson, Zelpha D’Souza, Helen Parker, Aiyin Liao, Samuel Rowlston, Hélène F.E. Gleitz, Shih‐hsin Kan, Patricia Dickson, Brian Bigger	2017	66
3	Human Macrophage Migration Inhibitory Factor Journal of Biological Chemistry ·Alex Kudrin, Martin Scott, Steven M. Martin, Chun‐wa Chung, Rachelle Donn, Andrew McMaster, Stuart Ellison, David Ray, Keith P. Ray, Michael Binks	2006	44
4	Pre-clinical Safety and Efficacy of Lentiviral Vector-Mediated Ex Vivo Stem Cell Gene Therapy for the Treatment of Mucopolysaccharidosis IIIA Molecular Therapy — Methods & Clinical Development ·Stuart Ellison, Aiyin Liao, Shaun Wood, Jessica Taylor, Amir Saam Youshani, Sam Rowlston, Helen Parker, Myriam Armant, Alessandra Biffi, Lucas Chan, Farzin Farzaneh, Robert Wynn, Simon Jones, Paul Heal, H. Bobby Gaspar, Brian Bigger	2019	39
5	Haematopoietic stem cell gene therapy with IL ‐1Ra rescues cognitive loss in mucopolysaccharidosis IIIA EMBO Molecular Medicine ·Helen Parker, Stuart Ellison, Rebecca Holley, Claire O’Leary, Aiyin Liao, Jalal Asadi, Emily Glover, Arunabha Ghosh, Simon Jones, Fiona L. Wilkinson, David Brough, Emmanuel Pinteaux, Hervé Boutin, Brian Bigger	2020	39
6	Enhanced pseudotyping efficiency of HIV-1 lentiviral vectors by a rabies/vesicular stomatitis virus chimeric envelope glycoprotein Gene Therapy ·David C. J. Carpentier, K Vevis, Antonio Trabalza, Christos Georgiadis, Stuart Ellison, R I Asfahani, ND Mazarakis	2011	33
7	Advances in therapies for neurological lysosomal storage disorders Journal of Inherited Metabolic Disease ·Stuart Ellison, Helen Parker, Brian Bigger	2023	28
8	CD148 enhances platelet responsiveness to collagen by maintaining a pool of active Src family kinases Journal of Thrombosis and Haemostasis ·Stuart Ellison, Jun Mori, A. Barr, Yotis A. Senis	2010	27
9	Dominant Role of the Protein-Tyrosine Phosphatase CD148 in Regulating Platelet Activation Relative to Protein-Tyrosine Phosphatase-1B Arteriosclerosis Thrombosis and Vascular Biology ·Jun Mori, Yingjie Wang, Stuart Ellison, Silke Heising, Benjamin G. Neel, Michel L. Tremblay, Steve P. Watson, Yotis A. Senis	2012	26
10	Genetic loci contributing to hemophagocytic lymphohistiocytosis do not confer susceptibility to systemic‐onset juvenile idiopathic arthritis Arthritis & Rheumatism ·Rachelle Donn, Stuart Ellison, Rebecca Lamb, Thomas G. Day, Eileen Baildam, Athimalaipet V Ramanan	2008	24
11	Actinomycin D downregulates Sox2 and improves survival in preclinical models of recurrent glioblastoma Neuro-Oncology ·Jessica Taylor, Stuart Ellison, Alina Pandele, Shaun Wood, Erica Nathan, Gabriella Forte, Helen Parker, Egor Zindy, Mark Elvin, Alan J. Dickson, Kaye J. Williams, Konstantina Karabatsou, Martin G. McCabe, Catherine McBain, Brian Bigger	2020	24
12	Vesicular Stomatitis Virus Glycoprotein– and Venezuelan Equine Encephalitis Virus-Derived Glycoprotein–Pseudotyped Lentivirus Vectors Differentially Transduce Corneal Endothelium, Trabecular Meshwork, and Human Photoreceptors Human Gene Therapy ·Daniel M. Lipinski, Alun R. Barnard, Peter Charbel Issa, Mandeep S. Singh, Samantha R. De Silva, Antonio Trabalza, Ioanna Eleftheriadou, Stuart Ellison, Nicholas D. Mazarakis, Robert E. MacLaren	2013	22
13	Dose-dependent Neuroprotection of VEGF165 in Huntington's Disease Striatum Molecular Therapy ·Stuart Ellison, Antonio Trabalza, Veronica Tisato, Evangelos Pazarentzos, Shirley Lee, Vasiliki Papadaki, Despoina Goniotaki, Sarah Morgan, Nazanin Mirzaei, Nicholas D. Mazarakis	2013	19
14	Specific Retrograde Transduction of Spinal Motor Neurons Using Lentiviral Vectors Targeted to Presynaptic NMJ Receptors Molecular Therapy ·Ioanna Eleftheriadou, Antonio Trabalza, Stuart Ellison, Kourosh Gharun, ND Mazarakis	2014	16
15	Venezuelan equine encephalitis virus glycoprotein pseudotyping confers neurotropism to lentiviral vectors Gene Therapy ·Antonio Trabalza, Christos Georgiadis, Ioanna Eleftheriadou, James N. Hislop, Stuart Ellison, Maria Elizabeth Karavassilis, Nicholas D. Mazarakis	2012	12
16	Ex-Vivo Autologous Stem Cell Gene Therapy Clinical Trial for Mucopolysaccharidosis Type IIIA: Trial in Progress - NCT04201405 Blood ·Jane Kinsella, Robert Wynn, Brian Bigger, Adrian J. Thrasher, Claire Booth, Karen Buckland, Natalia Izotova, Stewart Rust, Daniel Weisberg, Heather J. Church, Kathryn L. Brammeier, Karen Tylee, Ceri Jones, Helena Lee, Laura Ford, Atusa Sadegholnejat, Stuart Ellison, Simon Jones	2020	6
17	Sustained long-term disease correction in a murine model of MPSII following stem cell gene therapy Molecular Therapy — Methods & Clinical Development ·Stuart Ellison, Aiyin Liao, Hélène F.E. Gleitz, Helen Parker, Laura Booth, John E. Robinson, Shaun Wood, Jessica Taylor, Rebecca Holley, Brian Bigger	2023	5
18	Design and validation of a GMP stem cell manufacturing protocol for MPSII hematopoietic stem cell gene therapy Molecular Therapy — Methods & Clinical Development ·Stuart Ellison, Karen Buckland, Yuko Ishikawa Learmonth, Victoria Day, Spandan Kalra, Lauren Howe, Francisco J Roman‐Rodriguez, José Bonafont, Laura Booth, Rebecca Holley, Jon Smythe, Simon Jones, Adrian Thrasher, Claire Booth, Brian Bigger	2024	4
19	Sustained biochemical engraftment and early clinical outcomes following autologous stem cell gene therapy for mucopolysaccharidosis type IIIA Molecular Genetics and Metabolism ·Simon Jones, Jane Kinsella, Rebecca Holley, Jane E.R. Potter, Claire Booth, Karen Buckland, Stewart Rust, Heather J. Church, Kathryn L. Brammeier, Helena Lee, Laura Ford, Stuart Ellison, Brian Bigger, Robert Wynn	2023	2
20	Fusion of Rabies Virus Glycoprotein or gh625 to Iduronate-2-Sulfatase for the Treatment of Mucopolysaccharidosis Type II Human Gene Therapy ·Shaun Wood, Ahsan Chaudrhy, Stuart Ellison, Rachel Searle, Constance Burgod, Ghazala Tehseen, Gabriella Forte, Claire O’Leary, Hélène F.E. Gleitz, Aiyin Liao, James Cook, Rebecca Holley, Brian Bigger	2023	2

About Stuart Ellison

Stuart Ellison is a scholar working on Genetics, Physiology, Hematology, Cellular and Molecular Neuroscience and Genetics, having authored 27 papers that have together received 552 indexed citations. Recurring topics across this work include Lysosomal Storage Disorders Research (11 papers), Virus-based gene therapy research (6 papers), Neurogenetic and Muscular Disorders Research (4 papers), Autoimmune and Inflammatory Disorders Research (3 papers), CRISPR and Genetic Engineering (3 papers), Signaling Pathways in Disease (2 papers), Research on Leishmaniasis Studies (2 papers) and Neurological disorders and treatments (2 papers). The work is most often cited by research in Hematology (116 citations), Immunology and Allergy (45 citations), Physiology (147 citations), Immunology (112 citations) and Cell Biology (74 citations). Stuart Ellison has collaborated with scholars based in United Kingdom, United States and Germany. Frequent co-authors include Brian Bigger, Helen Parker, Yotis A. Senis, Antonio Trabalza, Steve P. Watson, Aiyin Liao, Jun Mori, Rebecca Holley, Rachelle Donn and Fiona L. Wilkinson. Their work appears in journals such as Molecular Genetics and Metabolism, Molecular Therapy — Methods & Clinical Development, Blood, Human Gene Therapy and Molecular Therapy.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact